Andreas Behren
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 37
- Cancer Immunotherapy and Biomarkers 19
- CAR-T cell therapy research 10
- Cancer Cells and Metastasis 7
- Immunology 28
- Immunotherapy and Immune Responses 17
- Immune Cell Function and Interaction 7
- T-cell and B-cell Immunology 6
- Co-authors
- Jonathan Cebon (46 shared papers)Matt Trau (8 shared papers)Yuling Wang (5 shared papers)Alexander Dobrovic (8 shared papers)Jing Wang (5 shared papers)Alain Wuethrich (6 shared papers)Matthew Anaka (14 shared papers)Abu Ali Ibn Sina (5 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Oncotarget (5 papers)Scientific Reports (4 papers)Frontiers in Immunology (4 papers)Cancer Immunology Research (3 papers)
- Partner nations
- AustraliaUnited StatesGermany
In The Last Decade
Andreas Behren
71 papers receiving 2.7k citations
Andreas Behren's Hit Papers
Peers
Comparison fields: 5 of 117
- Oncology 1.0k
- Cancer Research 470
- Immunology 600
- Molecular Biology 1.2k
- Biophysics 81
Countries citing papers authored by Andreas Behren
This map shows the geographic impact of Andreas Behren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Behren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Behren more than expected).
Fields of papers citing papers by Andreas Behren
This network shows the impact of papers produced by Andreas Behren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Behren. The network helps show where Andreas Behren may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas Behren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 196 | |
| 2 | Evaluation of Combination Nivolumab and Ipilimumab Immunotherapy in Patients With Advanced Biliary Tract Cancers Hit paper breakdown → | 2020 | 162 |
| 3 | 2019 | 146 | |
| 4 | 2015 | 145 | |
| 5 | 2020 | 143 | |
| 6 | 2021 | 122 | |
| 7 | 2020 | 122 | |
| 8 | 2014 | 113 | |
| 9 | 2013 | 108 | |
| 10 | 2018 | 100 | |
| 11 | A gut microbial signature for combination immune checkpoint blockade across cancer types Hit paper breakdown → | 2024 | 79 |
| 12 | 2018 | 77 | |
| 13 | 2021 | 76 | |
| 14 | 2017 | 57 | |
| 15 | 2022 | 52 | |
| 16 | 2016 | 50 | |
| 17 | 2018 | 50 | |
| 18 | 2012 | 46 | |
| 19 | 2013 | 45 | |
| 20 | 2020 | 44 |
About Andreas Behren
Andreas Behren is a scholar working on Oncology, Immunology, Molecular Biology, Cancer Research and Biomedical Engineering, having authored 72 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (19 papers), Immunotherapy and Immune Responses (17 papers), CAR-T cell therapy research (10 papers), Melanoma and MAPK Pathways (8 papers), Cancer Cells and Metastasis (7 papers), Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (6 papers) and Cancer Genomics and Diagnostics (5 papers). The work is most often cited by research in Oncology (1.0k citations), Cancer Research (470 citations), Immunology (600 citations), Molecular Biology (1.2k citations) and Biophysics (81 citations). Andreas Behren has collaborated with scholars based in Australia, United States and Germany. Frequent co-authors include Jonathan Cebon, Matt Trau, Yuling Wang, Alexander Dobrovic, Jing Wang, Alain Wuethrich, Matthew Anaka, Abu Ali Ibn Sina, Christopher Hudson and Simon Chang‐Hao Tsao. Their work appears in journals such as Journal of Clinical Oncology, Oncotarget, Scientific Reports, Frontiers in Immunology and Cancer Immunology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.